papillary thyroid carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Gender is not limited, but the number of men and women is equal. 2) Aged 18-60 years. 3) Before the operation, the subjects were willing and able to sign the informed consent approved by the Institutional Review Board (IRB), the Ethics Committee (EC) or the Ethics Review Board (ERB). 4) According to the judgement of clinical researchers, the subjects can understand the clinical research and cooperate with the research process. 5) Initial operation. 6) Admission diagnosis of "papillary thyroid carcinoma"(confirmed by FNA) 7) Preoperative cervical lymph node non-metastasis (cN0) and no distant metastasis
Exclusion criteria
Exclusion criteria: 1) Subjects could not provide written consent for voluntary participation in clinical research. 2) Eliminate chronic diseases, severe liver and kidney insufficiency, acute infectious diseases, autoimmune diseases, malignant tumors and other diseases. 3) Subjects had alcoholism or drug addiction and/or mental illness, and the researchers thought it might affect their participation in this study. 4) Subjects have diseases that restrict their participation in this study, fail to comply with follow-up requirements or affect the scientific integrity of the study. 5) Subjects are currently participating in another experimental drug or device study. 6) Preoperative local invasion such as trachea, esophagus, recurrent laryngeal nerve or cervical great vessels 7) Ambulatory surgery is not allowed because of cardiopulmonary insufficiency or any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| morbidity incidence;readmission rate within 30 days; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospitalization expenses;Intraoperative blood loss;Hospitalization Days; | — |
Countries
China
Contacts
Xiangya Hospital, Central South University